Voloridge Investment Management
PAVM icon

Voloridge Investment Management’s PAVmed PAVM Stock Holding History

Voloridge Investment Management’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-342
Closed -$379K – 1620
2021
Q4 		$379K Buy
342
+118
+53% +$256K ﹤0.01% 1448
2021
Q3 		$860K Buy
224
+33
+17% +$104K 0.01% 1327
2021
Q2 		$549K Buy
+191
New +$451K ﹤0.01% 1419

Other funds holding PAVM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Voloridge Investment Management's PAVM Position: Q1 2022 in Review

Voloridge Investment Management sold out of PAVmed (PAVM) in Q1 2022, closing a stake of 342 shares — an estimated $379K sold.

Voloridge Investment Management first reported a position in PAVM in Q2 2021 and held it in 3 quarters. The position peaked at $860K in Q3 2021. 94 funds tracked by Wall St. Rank hold PAVM as of Q1 2022.

  • Voloridge Investment Management reported no remaining PAVmed position as of Q1 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 342 PAVmed shares in Q1 2022, an estimated $379K.
  • Voloridge Investment Management first reported a position in PAVmed in Q2 2021 and held it in 3 quarters.
  • Voloridge Investment Management's PAVmed position peaked at $860K in Q3 2021.
  • 94 funds tracked by Wall St. Rank held PAVmed as of Q1 2022.

Based on Voloridge Investment Management's 13F filing for Q1 2022, filed 16 May 2022.